Neratinib
ATC L01EH02 · 6 markets · 7 records
US 2 records · 1 strengths
- 40 mgtabletNerlynx__no_trade__
GB 1 records · 1 strengths
- 40 mgtabletNerlynx
ES 1 records · 1 strengths
- 40 mgtabletNerlynx
MX 1 records · 1 strengths
Records without a stated strength · 1 Nerlynx
HK 1 records · 1 strengths
Records without a stated strength · 1 Nerlynx
EU 1 records · 1 strengths
EU centralised authorisation (EMA) — Authorised at EU level — not a record of sale in any single country. The EU register carries no strength, dosage form or pack size.
Records without a stated strength · 1 Nerlynx
| Strength / form / release | US | GB | ES | MX | HK | EU |
|---|---|---|---|---|---|---|
| 40 mg tablet | No trade name Nerlynx | Nerlynx | Nerlynx | |||
unknown | Nerlynx | Nerlynx | ||||
tablet | Nerlynx |
Scroll horizontally for more markets →
Each country column shows the locally registered trade names — not translations.
2 more strength/form rows are recorded only in MX · HK · EU and are not shown in this table. Hay 2 filas de concentración/forma registradas solo en MX · HK · EU que no se muestran en esta tabla. 另有 2 个规格/剂型仅在 MX · HK · EU 有记录(未在本表显示)。 另有 2 個規格/劑型僅在 MX · HK · EU 有記錄(未在本表顯示)。
“not disclosed” means the source does not publish the strength — it does not mean the product has none.
Hong Kong records are name/ingredient-level only: no strength, dosage form or registration status; on the register does not prove current supply.
EU centralised authorisation (EMA) — Authorised at EU level — not a record of sale in any single country. The EU register carries no strength, dosage form or pack size.
Discontinued, withdrawn or unverified-status products are hidden by default; Hong Kong and Australia records are shown as exceptions.